Harmonizing Post-Market Surveillance of Prescription Drug Misuse: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2013)
- 259 Downloads
Prescription drug misuse is a growing public health concern globally. Routinely collected data provide a valuable tool for quantifying prescription drug misuse.
To synthesize the global literature investigating prescription drug misuse utilizing routinely collected, person-level prescription/dispensing data to examine reported measures, documented extent of misuse and associated factors.
The MEDLINE, EMBASE, CINAHL, MEDLINE In Process, Scopus citations and Google Scholar databases were searched for relevant articles published between 1 January 2000 and 31 July 2013. A total of 10,803 abstracts were screened and 281 full-text manuscripts were retrieved. Fifty-two peer-reviewed, English-language manuscripts met our inclusion criteria—an aim/method investigating prescription drug misuse in adults and a measure of misuse derived exclusively from prescription/dispensing data.
Four proxies of prescription drug misuse were commonly used across studies: number of prescribers, number of dispensing pharmacies, early refills and volume of drugs dispensed. Overall, 89 unique measures of misuse were identified across the 52 studies, reflecting the heterogeneity in how measures are constructed: single or composite; different thresholds, cohort definitions and time period of assessment. Consequently, it was not possible to make definitive comparisons about the extent (range reported 0.01–93.5 %), variations and factors associated with prescription drug misuse.
Routine data collections are relatively consistent across jurisdictions. Despite the heterogeneity of the current literature, our review identifies the capacity to develop universally accepted metrics of misuse applied to a core set of variables in prescription/dispensing claims. Our timely recommendations have the potential to unify the global research field and increase the capacity for routine surveillance of prescription drug misuse.
The authors would like to thank Matthew Davis for assistance in refining the search strategies and for technical support.
This research has been supported, in part, by the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Medicines (APP1060407). Bianca Blanch is supported by a University of Sydney Postgraduate Award (2013–2016); Sallie-Anne Pearson is supported by a Cancer Institute New South Wales Career Development Fellowship (ID: 12/CDF/2-25); Nicholas Buckley and Andrew Dawson receive support for toxicovigilance studies through an NHMRC Program Grant (1055176); and Andrew Dawson is also supported by an NHRMC practitioner fellowship (1059542).
Conflict of interest
Bianca Blanch, Nicholas Buckley, Leigh Mellish, Andrew Dawson, Paul Haber and Sallie-Anne Pearson have no conflicts of interest that are directly relevant to the content of this study.
- 18.Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. NSDUH series H-46, HHS publication no. (SMA) 13-4795, 2013. Available at: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm#ch2. Accessed 1 May 2015.
- 24.US Department of Health & Human Services. Postmarketing requirements for the class-wide extended-release/long-acting opioid analgesics. 2014. Available at: http://www.fda.gov/drugs/newsevents/ucm384489.htm. Accessed 30 Jun 2014.
- 35.Bachs LC, Bramness JG, Engeland A, Skurtveit S. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Nor Epidemiol. 2008;18(2):185–90.Google Scholar
- 53.Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012;15(3 Suppl):ES191–203.Google Scholar
- 74.Frauger E, Pauly V, Natali F, et al. Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008. CNS Drugs. 2011;25(5):415–24.CrossRefPubMedGoogle Scholar
- 87.Hartz I, Tverdal A, Skurtveit S. Social inequalities in use of potentially addictive drugs in Norway: use among disability pensioners. Nor Epidemiol. 2009;19(2):209–18.Google Scholar